Yu‐Lueng Shih

2.5k total citations
88 papers, 1.8k citations indexed

About

Yu‐Lueng Shih is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Yu‐Lueng Shih has authored 88 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 22 papers in Epidemiology and 20 papers in Surgery. Recurrent topics in Yu‐Lueng Shih's work include Cancer-related gene regulation (18 papers), Liver Disease Diagnosis and Treatment (16 papers) and Epigenetics and DNA Methylation (16 papers). Yu‐Lueng Shih is often cited by papers focused on Cancer-related gene regulation (18 papers), Liver Disease Diagnosis and Treatment (16 papers) and Epigenetics and DNA Methylation (16 papers). Yu‐Lueng Shih collaborates with scholars based in Taiwan, United States and Japan. Yu‐Lueng Shih's co-authors include Ya‐Wen Lin, Tsai‐Yuan Hsieh, Ming‐De Yan, Yau‐Huei Wei, Wun‐Chang Ko, Chwen-Ming Shih, Hung‐Cheng Lai, Wei‐Kuo Chang, Heng-Cheng Chu and Peng‐Jen Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Yu‐Lueng Shih

79 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Lueng Shih Taiwan 22 944 373 331 318 244 88 1.8k
Ye Tao China 22 1.1k 1.2× 266 0.7× 452 1.4× 152 0.5× 200 0.8× 64 1.9k
Yuzo Kodama Japan 21 616 0.7× 371 1.0× 242 0.7× 349 1.1× 491 2.0× 104 2.1k
Hongtao Lu China 18 747 0.8× 146 0.4× 246 0.7× 283 0.9× 195 0.8× 65 1.6k
Yongtao Xiao China 21 490 0.5× 279 0.7× 225 0.7× 220 0.7× 419 1.7× 61 1.3k
Yan Meng China 21 443 0.5× 304 0.8× 222 0.7× 194 0.6× 234 1.0× 64 1.2k
Ursula Ehmer Germany 21 804 0.9× 199 0.5× 168 0.5× 366 1.2× 211 0.9× 52 1.6k
Monika Biniecka Ireland 23 952 1.0× 188 0.5× 365 1.1× 317 1.0× 125 0.5× 42 2.4k
Vincent W.S. Liu Hong Kong 22 1.1k 1.2× 345 0.9× 408 1.2× 156 0.5× 106 0.4× 31 1.7k
Jinhang Gao China 24 736 0.8× 657 1.8× 250 0.8× 149 0.5× 250 1.0× 72 1.7k
Hyun Mi Kang South Korea 14 1.2k 1.3× 338 0.9× 265 0.8× 133 0.4× 493 2.0× 35 2.7k

Countries citing papers authored by Yu‐Lueng Shih

Since Specialization
Citations

This map shows the geographic impact of Yu‐Lueng Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Lueng Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Lueng Shih more than expected).

Fields of papers citing papers by Yu‐Lueng Shih

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Lueng Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Lueng Shih. The network helps show where Yu‐Lueng Shih may publish in the future.

Co-authorship network of co-authors of Yu‐Lueng Shih

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Lueng Shih. A scholar is included among the top collaborators of Yu‐Lueng Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Lueng Shih. Yu‐Lueng Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Yu‐Ping, Ji‐Yuh Lee, Chi‐Yi Chen, et al.. (2025). Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection. Alimentary Pharmacology & Therapeutics. 61(9). 1508–1518. 1 indexed citations
2.
3.
4.
5.
Chang, Shan‐Yueh, Yu‐Lueng Shih, Ying‐Chieh Chen, et al.. (2023). SOX1 Functions as a Tumor Suppressor by Repressing HES1 in Lung Cancer. Cancers. 15(8). 2207–2207. 6 indexed citations
6.
7.
Liu, Chen‐Hua, Hsin‐Yun Sun, Cheng‐Yuan Peng, et al.. (2022). Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study. Open Forum Infectious Diseases. 9(8). ofac348–ofac348. 10 indexed citations
8.
Chang, Wei‐Chou, Hsian‐He Hsu, Wen‐Yen Huang, et al.. (2021). Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (. Journal of Hepatocellular Carcinoma. Volume 8. 937–949. 18 indexed citations
9.
Lin, Hsuan‐Hwai, Yu‐Lueng Shih, An‐Chieh Feng, et al.. (2021). CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation. Life Sciences. 284. 119708–119708. 12 indexed citations
10.
Chang, Shan‐Yueh, et al.. (2020). Epigenetic Silencing of LMX1A Contributes to Cancer Progression in Lung Cancer Cells. International Journal of Molecular Sciences. 21(15). 5425–5425. 5 indexed citations
11.
Chang, Shan‐Yueh, et al.. (2019). Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells. International Journal of Molecular Sciences. 20(23). 5914–5914. 19 indexed citations
12.
13.
Hsu, Kuo‐Feng, Jyh‐Cherng Yu, Chih‐Wei Yang, et al.. (2018). Long-term outcomes in elderly patients with resectable large hepatocellular carcinoma undergoing hepatectomy. Surgical Oncology. 27(3). 595–601. 8 indexed citations
14.
Huang, Hsin‐Hung, Tsai‐Yuan Hsieh, Wei‐Kuo Chang, et al.. (2014). Liver cirrhosis as a predisposing factor for esophageal candidiasis. Advances in digestive medicine. 1(3). 86–91. 7 indexed citations
15.
Lin, Ya‐Wen, et al.. (2013). SOX1 suppresses cell growth and invasion in cervical cancer. Gynecologic Oncology. 131(1). 174–181. 48 indexed citations
16.
Lin, Ya‐Wen, Ming‐De Yan, Yu‐Lueng Shih, & Chung-Bao Hsieh. (2009). The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma. European Journal of Cancer. 45(11). 2041–2049. 15 indexed citations
17.
Shih, Yu‐Lueng, et al.. (2008). Cadmium-induced autophagy and apoptosis are mediated by a calcium signaling pathway. Cellular and Molecular Life Sciences. 65(22). 3640–3652. 198 indexed citations
18.
Lin, Ya‐Wen, et al.. (2007). Epigenetic silencing of SFRP1 in hepatocellular carcinoma. Cancer Research. 67. 1147–1147. 1 indexed citations
19.
Shih, Yu‐Lueng, et al.. (2006). Promoter methylation of the secreted frizzled‐related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Cancer. 107(3). 579–590. 85 indexed citations
20.
Chao, Yee, Yu‐Lueng Shih, Jen‐Hwey Chiu, et al.. (1998). Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma.. PubMed. 58(5). 985–90. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ye Tao Breakdown of academic impact, for papers by Yuzo Kodama Breakdown of academic impact, for papers by Hongtao Lu Breakdown of academic impact, for papers by Yongtao Xiao Breakdown of academic impact, for papers by Yan Meng Breakdown of academic impact, for papers by Ursula Ehmer Breakdown of academic impact, for papers by Monika Biniecka Breakdown of academic impact, for papers by Vincent W.S. Liu Breakdown of academic impact, for papers by Jinhang Gao Breakdown of academic impact, for papers by Hyun Mi Kang
Rankless by CCL
2026